“The company on April 11, 2015 has allotted 1,100,000 warrants at a price of Rs 475 per warrant (including a premium of Rs 465 per warrant) convertible into 1,100,000 equity shares of Rs 10 to M/s. Pronomz Ventures LLP, a Promoter Group Entity,” Sequent Scientific said in a BSE filing.
The warrants are convertible into equity shares within a period of 18 months from the date of issue, it added.
Shares of pharmaceuticals firm has opened at Rs 566 and touched a high 608, also its record high on the BSE. Till 1029 hours, around 34,000 shares changed hands as against an average 47,000 shares that were traded daily on the BSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)